Research.Patient.info
Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE3
Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9
This study is looking into the long-term safety and effectiveness of a medicine called BBP-418 (ribitol) for people with a muscle condition called Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I). It's for people who've already taken part in an earlier study of this medicine.
United States · Australia · Denmark - active not recruitingPHASE3
Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)
This study is looking into a new medication called BBP-418 (also known as ribitol) for people with a muscle condition called Limb-Girdle Muscular Dystrophy type 2I (LGMD2I). It aims to see if the medication is safe and helps improve their condition.
United States · Australia · Denmark